KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Cash from Financing Activities (2016 - 2025)

LifeMD filings provide 14 years of Cash from Financing Activities readings, the most recent being -$788562.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities fell 507.68% to -$788562.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$13.4 million, a 304.61% decrease, with the full-year FY2025 number at -$13.4 million, down 304.61% from a year prior.
  • Cash from Financing Activities hit -$788562.0 in Q4 2025 for LifeMD, up from -$8.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $39.3 million in Q4 2021 to a low of -$8.7 million in Q3 2025.
  • Median Cash from Financing Activities over the past 5 years was -$763737.5 (2022), compared with a mean of $4.0 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 1649.16% in 2023 and later plummeted 558.85% in 2025.
  • LifeMD's Cash from Financing Activities stood at $39.3 million in 2021, then crashed by 95.26% to $1.9 million in 2022, then soared by 671.21% to $14.4 million in 2023, then tumbled by 100.9% to -$129765.0 in 2024, then plummeted by 507.68% to -$788562.0 in 2025.
  • The last three reported values for Cash from Financing Activities were -$788562.0 (Q4 2025), -$8.7 million (Q3 2025), and -$3.1 million (Q2 2025) per Business Quant data.